These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33174482)

  • 1. Race-Specific Prevalence of Hidradenitis Suppurativa.
    Sachdeva M; Shah M; Alavi A
    J Cutan Med Surg; 2021; 25(2):177-187. PubMed ID: 33174482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the race-specific prevalence of hidradenitis suppurativa at a large academic center; results from a retrospective chart review.
    Vaidya T; Vangipuram R; Alikhan A
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race and Ethnicity Gaps in Global Hidradenitis Suppurativa Clinical Trials.
    Price KN; Hsiao JL; Shi VY
    Dermatology; 2021; 237(1):97-102. PubMed ID: 31865334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States.
    Garg A; Kirby JS; Lavian J; Lin G; Strunk A
    JAMA Dermatol; 2017 Aug; 153(8):760-764. PubMed ID: 28492923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic Gaps and Requirements for Participation: A Systematic Review of Clinical Trial Designs in Hidradenitis Suppurativa.
    James JF; Madray VM; Salame N; Hasan SB; White MS; Barron JR; Kirby J; Ingram JR; Orenstein LAV
    Dermatology; 2023; 239(1):45-51. PubMed ID: 36108592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnoracial representation in hidradenitis suppurativa clinical trials.
    Elhage KG; Davis MS; Hakimi M; Spencer RK; Jin JQ; Yeroushalmi S; Chung M; Bartholomew E; Bhutani T; Liao W
    Arch Dermatol Res; 2023 Aug; 315(6):1793-1796. PubMed ID: 36509944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African American race is a risk factor for severe hidradenitis suppurativa.
    Ulschmid C; Serrano L; Wu R; Roth GM; Sokumbi O
    Int J Dermatol; 2023 May; 62(5):657-663. PubMed ID: 36183313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis suppurativa and chromosomal abnormalities: a case report and systematic review of the literature.
    Shah M; Sachdeva M; Melendez-Gonzalez M; Piguet V; Sayed C
    Int J Dermatol; 2021 Mar; 60(3):261-271. PubMed ID: 33599294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive correlation of hidradenitis suppurativa and ultra-processed foods consumption.
    Haddad NR; Badiei B; Williams KL; Garza LA
    Arch Dermatol Res; 2024 May; 316(5):172. PubMed ID: 38758298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic and clinical features of hidradenitis suppurativa.
    Parulkar I; Haleem H; Paek SY
    Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia in patients with hidradenitis suppurativa : A systematic review with meta-analysis.
    Revankar R; Rojas M; Walsh S; Patel H; Revankar N; Han J; Parameswaran A
    Arch Dermatol Res; 2023 Aug; 315(6):1639-1648. PubMed ID: 36781458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Hidradenitis Suppurativa in an African Population: Validation of a Screening Questionnaire in Lagos, Nigeria.
    Anaba EL; Bouazzi D; Ajayi PV; Aro OO; Boer J; Jemec GBE
    Dermatology; 2023; 239(5):832-835. PubMed ID: 37343527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
    Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
    JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis.
    Garg A; Lavian J; Lin G; Strunk A; Alloo A
    J Am Acad Dermatol; 2017 Jul; 77(1):118-122. PubMed ID: 28285782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between hidradenitis suppurativa and dermatological conditions in adults: a national cross-sectional study.
    Brown ID; Adawi W; Saal R; Perkins-Holtsclaw K; Roberts A
    Clin Exp Dermatol; 2023 Apr; 48(5):524-527. PubMed ID: 36702792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric hidradenitis suppurativa publication trends: 2012 to 2022.
    Park SE; Shih T; Dagenet C; Hogeling M; Hughes M; Gillenwater J; Shi VY; Hsiao JL
    Pediatr Dermatol; 2024; 41(3):472-475. PubMed ID: 38409741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates - Italian Registry Hidradenitis Suppurativa project 2.
    Bettoli V; Cazzaniga S; Scuderi V; Zedde P; Di Landro A; Naldi L;
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():4-6. PubMed ID: 31535758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
    Shlyankevich J; Chen AJ; Kim GE; Kimball AB
    J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of permanent stoma in Crohn's disease associated with hidradenitis suppurativa: a case-control study.
    Dumont LM; Landman C; Sokol H; Beaugerie L; Cosnes J; Seksik P; Guégan S;
    Aliment Pharmacol Ther; 2020 Jul; 52(2):303-310. PubMed ID: 32525586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.